Related Experiment Videos
Modulation of growth factor action: implications for the treatment of cardiovascular diseases
1Department of Internal Medicine II (Cardiology), Ulm University Medical Center, Germany. johannes.waltenberger@medizin.uni-ulm.de
Abstract:
Peptide growth factors are involved in fundamental cellular processes relevant for cardiovascular physiology and pathology, namely, atherogenesis and angiogenesis. The modulation of growth factor-related signals represents a novel strategy for the treatment of cardiac and vascular disease. Experimental modulation of growth factor action has already provided a better understanding of cardiovascular biology and pathophysiology. In turn, the development of specific and powerful molecular tools is setting the stage for the exploration of their clinical potentials. Current strategies include the use of recombinant proteins, specific inhibitors of protein-protein interactions, tyrosine kinase inhibitors, the generation and application of dominant-negative molecules, the development of antisense strategies, and a variety of different gene transfer approaches. Parallel avenues of research are heading toward the same goal, the specific suppression of potent pathogenic stimuli that induce and promote atherogenesis or the augmentation of beneficial ones such as induction of therapeutic angiogenesis. The successful application of one of these strategies seems to be in reach and will certainly be a milestone in molecular medicine.
Insights
Peptide growth factors are key in cardiovascular health and disease. Modulating these signals offers a promising new strategy for treating cardiac and vascular conditions.
Area of Science:
- Cardiovascular Biology and Disease
- Molecular Medicine
- Growth Factor Signaling
Background:
- Peptide growth factors play fundamental roles in cellular processes, impacting cardiovascular physiology and pathology, including atherogenesis and angiogenesis.
- Understanding growth factor signaling is crucial for developing novel therapeutic strategies for cardiovascular diseases.
- Existing research has enhanced our comprehension of cardiovascular biology and pathophysiology through experimental growth factor modulation.
Purpose of the Study:
- To explore the potential of modulating growth factor-related signals as a novel therapeutic strategy for cardiac and vascular diseases.
- To highlight the development of molecular tools for investigating the clinical applications of growth factor modulation.
- To discuss strategies for either suppressing pathogenic stimuli or augmenting beneficial growth factors in cardiovascular disease.
Main Methods:
- Utilizing recombinant proteins and specific inhibitors of protein-protein interactions.
- Employing tyrosine kinase inhibitors and dominant-negative molecules.
- Developing antisense strategies and gene transfer approaches for therapeutic intervention.
Main Results:
- Experimental modulation has improved understanding of cardiovascular biology and pathophysiology.
- Various molecular tools are advancing the exploration of clinical potentials for growth factor modulation.
- Research focuses on suppressing atherogenesis-promoting stimuli and enhancing therapeutic angiogenesis.
Conclusions:
- Modulating growth factor signals represents a novel and promising strategy for treating cardiovascular and vascular diseases.
- The development of advanced molecular tools is paving the way for clinical applications.
- Successful implementation of these strategies will mark a milestone in molecular medicine for cardiovascular health.